Study on the Molecular Mechanism of RBM5 Reverse the Acquired Resistance to EGFR-TKI

被引：0
|
作者：
Zhang, J. [1 ]
Xu, Y. [1 ]
Su, Z. [1 ]
Li, J. [2 ]
Wang, Q. [1 ]
Zhang, L. [1 ]
机构：
[1] Jilin Univ, Affiliated Hosp 2, Dept Resp Med, Changchun, Jilin, Peoples R China
[2] Jilin Univ, Hosp 2, Changchun, Jilin, Peoples R China
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2018年 / 197卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A7794
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Overcoming EGFR-TKI resistance in EGFR-mutated lung cancer
    Gardizi, M.
    Scheffler, M.
    Bos, M.
    Geist, T.
    Heukamp, L.
    Nogova, L.
    Toepelt, K.
    Fernandez-Cuesta, L.
    Culmann, H.
    Kaminsky, B.
    Panse, J.
    Becker, C.
    Mattonet, C.
    Serke, M.
    Schmitz, S.
    Schnell, R.
    Galetke, W.
    Hekmat, K.
    Buettner, R.
    Wolf, J.
    [J]. ONKOLOGIE, 2013, 36 : 30 - 30
  • [42] Acquired Resistance Mechanisms to Combination Met-TKI/EGFR-TKI Exposure in Met-Amplified EGFR-TKI-Resistant Lung Adenocarcinoma Harboring an Activating EGFR Mutation
    Yamaoka, Toshimitsu
    Ohmori, Tohru
    Ohba, Motoi
    Arata, Satoru
    Kishino, Yasunari
    Murata, Yasunori
    Kusumoto, Sojiro
    Ishida, Hiroo
    Shirai, Takao
    Hirose, Takashi
    Ohnishi, Tsukasa
    Sasaki, Yasutsuna
    [J]. MOLECULAR CANCER THERAPEUTICS, 2016, 15 (12) : 3040 - 3054
  • [43] In vitro study on blocking mTOR signaling pathway in EGFR-TKI resistance NSCLC
    Xu-Dong Xiang
    Jing Yu
    Gao-Feng Li
    Lin Xie
    Heng Li
    [J]. Asian Pacific Journal of Tropical Medicine, 2014, (05) : 394 - 397
  • [44] EGFR-TKI rechallenged treatment combined with apatinib in non-small cell lung cancer with EGFR-TKI resistance.
    Liang, Li
    Li, Fang
    Cao, Baoshan
    Zhang, Zhaohui
    Zhu, Xiang
    Wang, Jiadong
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [45] Efficacy and safety of apatinib plus EGFR-TKI in advanced non-small cell lung cancer with EGFR-TKI resistance
    Tian, R.
    [J]. ANNALS OF ONCOLOGY, 2021, 32 : S980 - S981
  • [46] Combining EGFR-TKI With SAHA Overcomes EGFR-TKI-Acquired Resistance by Reducing the Protective Autophagy in Non-Small Cell Lung Cancer
    Cao, Peijun
    Li, Yongwen
    Shi, Ruifeng
    Yuan, Yin
    Gong, Hao
    Zhu, Guangsheng
    Zhang, Zihe
    Chen, Chen
    Zhang, Hongbing
    Liu, Minghui
    Pan, Zhenhua
    Liu, Hongyu
    Chen, Jun
    [J]. FRONTIERS IN CHEMISTRY, 2022, 10
  • [47] In vitro study on blocking mTOR signaling pathway in EGFR-TKI resistance NSCLC
    Xiang, Xu-Dong
    Yu, Jing
    Li, Gao-Feng
    Xie, Lin
    Li, Heng
    [J]. ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE, 2014, 7 (05) : 394 - 397
  • [48] Aberrant activation of MET signaling induces acquired resistance to osimertinib in EGFR-TKI naive NSCLC cells
    Ito, Kimihiro
    Ohkubo, Shuichi
    Matsuo, Kenichi
    [J]. CANCER SCIENCE, 2018, 109 : 563 - 563
  • [49] Concomitant SBRT and EGFR-TKI Versus EGFR-TKI Alone for Oligometastatic NSCLC: A Multicenter, Randomized Phase II Study
    Peng, P.
    Chen, Y.
    Han, G.
    Meng, R.
    Zhang, S.
    Liao, Z.
    Zhang, Y.
    Gong, J.
    Xiao, C.
    Liu, X.
    Zhang, P.
    Zhang, L.
    Xia, S.
    Chu, Q.
    Chen, Y.
    Zhang, L.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S250 - S251
  • [50] Multimutational profiling of rebiopsy samples from NSCLC developing acquired resistance to EGFR-TKI in Japanese patients
    Ko, Ryo
    Kenmotsu, Hirotsugu
    Serizawa, Masakuni
    Koh, Yasuhiro
    Omori, Shots
    Nakashima, Kazuhlsa
    Oyakawa, Takuya
    Wakuda, Kazushige
    Hisamatsu, Yasushi
    Ono, Akira
    Imai, Hisao
    Taira, Tetsuhiko
    Naito, Tateaki
    Murakami, Haruyasu
    Make, Milsuhiro
    Endo, Masahiro
    Nakajima, Takashi
    Ohde, Yasuhisa
    Yamamoto, Nobuyuki
    Takahashi, Toshiaki
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
12345